Cargando…

The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease

BACKGROUND: The AMC Linear Disability Score (ALDS) is a calibrated generic itembank to measure the level of physical disability in patients with chronic diseases. The ALDS has already been validated in different patient populations suffering from chronic diseases. The aim of this study was to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Met, Rosemarie, Reekers, Jim A, Koelemay, Mark JW, Legemate, Dink A, de Haan, Rob J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766362/
https://www.ncbi.nlm.nih.gov/pubmed/19822016
http://dx.doi.org/10.1186/1477-7525-7-88
_version_ 1782173210656112640
author Met, Rosemarie
Reekers, Jim A
Koelemay, Mark JW
Legemate, Dink A
de Haan, Rob J
author_facet Met, Rosemarie
Reekers, Jim A
Koelemay, Mark JW
Legemate, Dink A
de Haan, Rob J
author_sort Met, Rosemarie
collection PubMed
description BACKGROUND: The AMC Linear Disability Score (ALDS) is a calibrated generic itembank to measure the level of physical disability in patients with chronic diseases. The ALDS has already been validated in different patient populations suffering from chronic diseases. The aim of this study was to assess the clinimetric properties of the ALDS in patients with peripheral arterial disease. METHODS: Patients with intermittent claudication (IC) and critical limb ischemia (CLI) presenting from January 2007 through November 2007 were included. Risk factors for atherosclerosis, ankle/brachial index and toe pressure, the Vascular Quality of Life Questionnaire (VascuQol), and the ALDS were recorded. To compare ALDS and VascuQol scores between the two patient groups, an unpaired t-test was used. Correlations were determined between VascuQol, ALDS and pressure measurements. RESULTS: Sixty-two patients were included (44 male, mean ± sd age was 68 ± 11 years) with IC (n = 26) and CLI (n = 36). The average ALDS was significantly higher in patients with IC (80, ± 10) compared to patients with CLI (64, ± 18). Internal reliability consistency of the ALDS expressed as Cronbach's α coefficient was excellent (α > 0.90). There was a strong convergent correlation between the ALDS and the disability related Activity domain of the VascuQol (r = 0.64). CONCLUSION: The ALDS is a promising clinimetric instrument to measure disability in patients with various stages of peripheral arterial disease.
format Text
id pubmed-2766362
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27663622009-10-24 The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease Met, Rosemarie Reekers, Jim A Koelemay, Mark JW Legemate, Dink A de Haan, Rob J Health Qual Life Outcomes Research BACKGROUND: The AMC Linear Disability Score (ALDS) is a calibrated generic itembank to measure the level of physical disability in patients with chronic diseases. The ALDS has already been validated in different patient populations suffering from chronic diseases. The aim of this study was to assess the clinimetric properties of the ALDS in patients with peripheral arterial disease. METHODS: Patients with intermittent claudication (IC) and critical limb ischemia (CLI) presenting from January 2007 through November 2007 were included. Risk factors for atherosclerosis, ankle/brachial index and toe pressure, the Vascular Quality of Life Questionnaire (VascuQol), and the ALDS were recorded. To compare ALDS and VascuQol scores between the two patient groups, an unpaired t-test was used. Correlations were determined between VascuQol, ALDS and pressure measurements. RESULTS: Sixty-two patients were included (44 male, mean ± sd age was 68 ± 11 years) with IC (n = 26) and CLI (n = 36). The average ALDS was significantly higher in patients with IC (80, ± 10) compared to patients with CLI (64, ± 18). Internal reliability consistency of the ALDS expressed as Cronbach's α coefficient was excellent (α > 0.90). There was a strong convergent correlation between the ALDS and the disability related Activity domain of the VascuQol (r = 0.64). CONCLUSION: The ALDS is a promising clinimetric instrument to measure disability in patients with various stages of peripheral arterial disease. BioMed Central 2009-10-12 /pmc/articles/PMC2766362/ /pubmed/19822016 http://dx.doi.org/10.1186/1477-7525-7-88 Text en Copyright © 2009 Met et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Met, Rosemarie
Reekers, Jim A
Koelemay, Mark JW
Legemate, Dink A
de Haan, Rob J
The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
title The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
title_full The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
title_fullStr The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
title_full_unstemmed The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
title_short The AMC Linear Disability Score (ALDS): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
title_sort amc linear disability score (alds): a cross-sectional study with a new generic instrument to measure disability applied to patients with peripheral arterial disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766362/
https://www.ncbi.nlm.nih.gov/pubmed/19822016
http://dx.doi.org/10.1186/1477-7525-7-88
work_keys_str_mv AT metrosemarie theamclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT reekersjima theamclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT koelemaymarkjw theamclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT legematedinka theamclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT dehaanrobj theamclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT metrosemarie amclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT reekersjima amclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT koelemaymarkjw amclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT legematedinka amclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease
AT dehaanrobj amclineardisabilityscorealdsacrosssectionalstudywithanewgenericinstrumenttomeasuredisabilityappliedtopatientswithperipheralarterialdisease